These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28342204)

  • 1. The EP4 antagonist, L-161,982, induces apoptosis, cell cycle arrest, and inhibits prostaglandin E2-induced proliferation in oral squamous carcinoma Tca8113 cells.
    Li X; Yang B; Han G; Li W
    J Oral Pathol Med; 2017 Nov; 46(10):991-997. PubMed ID: 28342204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of prostaglandin E2 receptors in oral squamous cell carcinomas and growth inhibitory effects of an EP3 selective antagonist, ONO-AE3-240.
    Hoshikawa H; Goto R; Mori T; Mitani T; Mori N
    Int J Oncol; 2009 Mar; 34(3):847-52. PubMed ID: 19212690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin E2 promotes proliferation of skeletal muscle myoblasts via EP4 receptor activation.
    Mo C; Zhao R; Vallejo J; Igwe O; Bonewald L; Wetmore L; Brotto M
    Cell Cycle; 2015; 14(10):1507-16. PubMed ID: 25785867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct growth-inhibitory effects of prostaglandin E2 in pancreatic cancer cells in vitro through an EP4/PKA-mediated mechanism.
    Schmidt A; Sinnett-Smith J; Young S; Chang HH; Hines OJ; Dawson DW; Rozengurt E; Eibl G
    Surgery; 2017 Jun; 161(6):1570-1578. PubMed ID: 28222855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of apoptosis and cell cycle arrest by NS398 in oral squamous cell carcinoma cells via downregulation of E2 promoter-binding factor-1.
    Du Y; Zhang S; Wang Z; Zhou W; Luan M; Yang X; Chen N
    Oncol Rep; 2008 Sep; 20(3):605-11. PubMed ID: 18695912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular inhibition of prostaglandin E2 with GW627368X: Therapeutic potential and preclinical safety assessment in mouse sarcoma model.
    Parida S; Parekh A; Dey G; Ghosh SC; Mandal M
    Cancer Biol Ther; 2015; 16(6):922-32. PubMed ID: 25894216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the EP receptor subtype that mediates the inhibitory effects of prostaglandin E2 on IgE-dependent secretion from human lung mast cells.
    Kay LJ; Gilbert M; Pullen N; Skerratt S; Farrington J; Seward EP; Peachell PT
    Clin Exp Allergy; 2013 Jul; 43(7):741-51. PubMed ID: 23786281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin E2 promotes the cell growth and invasive ability of hepatocellular carcinoma cells by upregulating c-Myc expression via EP4 receptor and the PKA signaling pathway.
    Xia S; Ma J; Bai X; Zhang H; Cheng S; Zhang M; Zhang L; Du M; Wang Y; Li H; Rong R; Shi F; Yang Q; Leng J
    Oncol Rep; 2014 Oct; 32(4):1521-30. PubMed ID: 25109834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin E2 stimulates normal bronchial epithelial cell growth through induction of c-Jun and PDK1, a kinase implicated in oncogenesis.
    Fan Y; Wang Y; Wang K
    Respir Res; 2015 Dec; 16():149. PubMed ID: 26684827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of PGE
    Huang H; Aladelokun O; Ideta T; Giardina C; Ellis LM; Rosenberg DW
    Sci Rep; 2019 Mar; 9(1):4954. PubMed ID: 30894570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
    Wang D; Fu L; Sun H; Guo L; DuBois RN
    Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of endogenous prostaglandin E2 in tubular epithelial regeneration through inhibition of apoptosis and epithelial-mesenchymal transition in cisplatin-induced rat renal lesions.
    Yamamoto E; Izawa T; Juniantito V; Kuwamura M; Sugiura K; Takeuchi T; Yamate J
    Histol Histopathol; 2010 Aug; 25(8):995-1007. PubMed ID: 20552550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The EP4 receptor antagonist, L-161,982, blocks prostaglandin E2-induced signal transduction and cell proliferation in HCA-7 colon cancer cells.
    Cherukuri DP; Chen XB; Goulet AC; Young RN; Han Y; Heimark RL; Regan JW; Meuillet E; Nelson MA
    Exp Cell Res; 2007 Aug; 313(14):2969-79. PubMed ID: 17631291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclooxygenase-2-dependent prostaglandin E2 down-regulates intercellular adhesion molecule-1 expression via EP2/EP4 receptors in interleukin-1beta-stimulated human gingival fibroblasts.
    Noguchi K; Iwasaki K; Shitashige M; Endo H; Kondo H; Ishikawa I
    J Dent Res; 2000 Dec; 79(12):1955-61. PubMed ID: 11201045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin EP4 receptor enhances BCR-induced apoptosis of immature B cells.
    Prijatelj M; Celhar T; Mlinaric-Rascan I
    Prostaglandins Other Lipid Mediat; 2011 Aug; 95(1-4):19-26. PubMed ID: 21600299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonist of prostaglandin E2 receptor 4 induces metabolic alterations in liver of mice.
    Li N; Zhang L; An Y; Zhang L; Song Y; Wang Y; Tang H
    J Proteome Res; 2015 Mar; 14(3):1566-73. PubMed ID: 25669961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin E2 receptor EP4 as the common target on cancer cells and macrophages to abolish angiogenesis, lymphangiogenesis, metastasis, and stem-like cell functions.
    Majumder M; Xin X; Liu L; Girish GV; Lala PK
    Cancer Sci; 2014 Sep; 105(9):1142-51. PubMed ID: 24981602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin E2 promotes cell survival of glomerular epithelial cells via the EP4 receptor.
    Aoudjit L; Potapov A; Takano T
    Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1534-42. PubMed ID: 16396944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins enhance rotator cuff healing by stimulating the COX2/PGE2/EP4 pathway: an in vivo and in vitro study.
    Dolkart O; Liron T; Chechik O; Somjen D; Brosh T; Maman E; Gabet Y
    Am J Sports Med; 2014 Dec; 42(12):2869-76. PubMed ID: 25184246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Operculina turpethum extract inhibits growth and proliferation by inhibiting NF-κB, COX-2 and cyclin D1 and induces apoptosis by up regulating P53 in oral cancer cells.
    Arora R; Bharti V; Gaur P; Aggarwal S; Mittal M; Das SN
    Arch Oral Biol; 2017 Aug; 80():1-9. PubMed ID: 28351666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.